People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Hubble Therapeutics, LLC | — | Biotechnology | Series A | $9.8M | $45.1M | 2024 |
| Bone Health Technologies, Inc. | — | Biotechnology | Seed | $3.7M | $29.8M | 2023 |
| SurgiBox Inc. | — | Biotechnology | Pre-Seed | $1.0M | $751K | 2023 |
Sam Goldberger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sam Goldberger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Burnett | 1 | 11 |
| Daniel Brown | 1 | 6 |
| John Osborne | 1 | 5 |
| Jeff Sabados | 1 | 1 |
| Greg Keenan | 1 | 1 |
| Kelly Laurel | 1 | 1 |
| Atif Rakin | 1 | 1 |
| Mike Teodorescu | 1 | 1 |
| Debbie Teodorescu | 1 | 1 |
| Julian Greene | 1 | 1 |
| Sashidhar Jonnalagedda | 1 | 1 |
| Macauley Kenney | 1 | 1 |
| Robert Smalley | 1 | 1 |
| Laura Yecies | 1 | 1 |
| Shane Mangrum | 1 | 1 |
| Marcie Hamilton | 1 | 1 |
| Pamela Peeke | 1 | 1 |
| Kian Beyzavi | 1 | 1 |
| Michael Jaasma | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.